1. Vertex Pharmaceuticals, Inc.
  2. Vertex Pharmaceuticals, Inc. Ownership

Historical shareholding details of Lazard Asset Management LLC holdings in Vertex Pharmaceuticals, Inc. (VRTX)

Monthly changes of Lazard Asset Management LLC shareholding in Vertex Pharmaceuticals, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Lazard Asset Management Llc 6,907 0.00%
Jan 31, 2025 Lazard Asset Management Llc 6,907 0.00%
Dec 31, 2024 Lazard Asset Management Llc 526,119 0.20%
Dec 31, 2024 Lazard Asset Management Llc 6,907 0.00%
Nov 30, 2024 Lazard Asset Management Llc 249 0.00%
Oct 31, 2024 Lazard Asset Management Llc 249 0.00%
Sep 30, 2024 Lazard Asset Management Llc 7,987 0.00%
Sep 30, 2024 Lazard Asset Management Llc 249 0.00%
Aug 31, 2024 Lazard Asset Management Llc 11,128 0.00%
Jul 31, 2024 Lazard Asset Management Llc 11,303 0.00%
Jun 30, 2024 Lazard Asset Management Llc 122,456 0.05%
Jun 30, 2024 Lazard Asset Management Llc 9,977 0.00%
May 31, 2024 Lazard Asset Management Llc 10,345 0.00%
Apr 30, 2024 Lazard Asset Management Llc 10,246 0.00%
Mar 31, 2024 Lazard Asset Management Llc 123,883 0.05%
Mar 31, 2024 Lazard Asset Management Llc 10,283 0.00%
Feb 29, 2024 Lazard Asset Management Llc 9,131 0.00%
Jan 31, 2024 Lazard Asset Management Llc 9,043 0.00%
Dec 31, 2023 Lazard Asset Management Llc 119,789 0.05%
Dec 31, 2023 Lazard Asset Management Llc 10,401 0.00%
Nov 30, 2023 Lazard Asset Management Llc 10,603 0.00%
Oct 31, 2023 Lazard Asset Management Llc 10,899 0.00%
Sep 30, 2023 Lazard Asset Management Llc 118,956 0.05%
Sep 30, 2023 Lazard Asset Management Llc 14,288 0.01%
Aug 31, 2023 Lazard Asset Management Llc 14,288 0.01%
Jul 31, 2023 Lazard Asset Management Llc 14,288 0.01%
Jun 30, 2023 Lazard Asset Management Llc 119,716 0.05%
Jun 30, 2023 Lazard Asset Management Llc 19,397 0.01%
May 31, 2023 Lazard Asset Management Llc 19,401 0.01%
Mar 31, 2023 Lazard Asset Management Llc 127,530 0.05%
Dec 31, 2022 Lazard Asset Management Llc 142,441 0.06%

View all ownership details of Vertex Pharmaceuticals, Inc.